…
The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended December 2024, but…
Pfizers late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS with…
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach Zahlen auf "Neutral" mit einem Kursziel…
These are the stocks posting the largest moves in premarket trading.…
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…
Der US-Pharmakonzern und Partner von BioNTech, Pfizer, hat am heutigen Dienstag seine Zahlen für das vierte Quartal sowie das Gesamtjahr…
Der US-Pharmakonzern und Partner von BioNTech, Pfizer, hat am heutigen Dienstag seine Zahlen für das vierte Quartal sowie das Gesamtjahr…
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen Ausblick für das neue…
NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…
…
U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and better-than-expected sales of…
Pfizer Inc (NYSE:PFE, ETR:PFE) posted stronger-than-expected financial results for the fourth quarter and reaffirmed its 2025 revenue guidance. The company...…
Pfizer Inc (NYSE:PFE, ETR:PFE) posted stronger-than-expected financial results for the fourth quarter and reaffirmed its 2025 revenue guidance. The company...…
Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb are included in this Analyst Blog.…
Pfizer (PFE) put up its most impressive quarterly numbers in recent memory today.…
Pfizer wird am 04.02.2025 in der Finanzkonferenz die Quartalszahlen zum jüngsten Jahresviertel - Abschlussdatum 31.12.2024 - vorstellen.16 Analysten gehen in…
Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…
…
Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years,…
There are thousands of publicly traded stocks, and dozens that could be considered artificial intelligence (AI) stocks.
So, lets sift through…
Dividend stocks can provide you with a lot of recurring income over the long term. But they can also prove…
Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to…
Pfizer resolves conservative challenge to diversity fellowship program…
Pfizer director Daniel Cronin sells shares worth $20,140…
The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help developers forge ahead on…
New York (www.aktiencheck.de) - Pfizer-Aktienanalyse der Citigroup:
1. Kurszielsenkung und Begründung
Analyst Geoff Meacham hat das Kursziel für die Aktie von Pfizer…
Yesterday, a piece of breaking news sent technology stocks into a tailspin. The Chinese start-up DeepSeek developed an AI chatbot…
When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to the S&P 500 over holding periods…
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to…
A Bloomberg article suggests activist investor Starboard cut Pfizer some slack by not nominating any director on the companys board…
Dividend stocks can be a great way to boost your portfolios growth potential or provide a form of passive income…
…
Dividend stocks make great long-term investments. For example, an investor who bought $100 worth of average dividend stocks in 1973…
Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable…
…
Der Pharmakonzern Pfizer verzeichnete am Freitag einen deutlichen Kursrückgang an der New Yorker Börse. Die Aktie des Unternehmens rutschte um…
Pfizer to pay $59.7 million over kickbacks for migraine drug…
…
In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. But…
Its the start of a new year, and that makes now the perfect time to load up on stocks that…
How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever.…
Youve probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the…
Its normal to make more than a few flubs while investing, especially when youre new. At the same time, we…
What would it take to make over $3,000 this year with only barely lifting a finger? My answer is having…
A little money can go a long way. Thats especially the case when you invest in stocks that pay you…
Exchange-traded funds (ETFs) are great options for those seeking to generate passive income. Many of these funds hold a portfolio…
Dividend yields can be like ladders: The higher you go, the scarier it gets. Many of us are more afraid…
The talks around drugs including Novo Nordisks Wegovy, GSKs Trelegy Ellipta, and Pfizers Xtandi will set Medicare prices that go…
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in…